+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 20329-98-0
20329-98-0,MFCD00004388
Catalog No.:AA00BC13

20329-98-0 | 3,4,5-TRIMETHOXYCINNAMIC ACID

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
98%
in stock  
$6.00   $4.00
- +
10g
98%
in stock  
$8.00   $6.00
- +
100g
98%
in stock  
$56.00   $39.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BC13
Chemical Name:
3,4,5-TRIMETHOXYCINNAMIC ACID
CAS Number:
20329-98-0
Molecular Formula:
C12H14O5
Molecular Weight:
238.2366
MDL Number:
MFCD00004388
SMILES:
COc1cc(/C=C/C(=O)O)cc(c1OC)OC
NSC Number:
66175
Properties
Computed Properties
 
Complexity:
262  
Covalently-Bonded Unit Count:
1  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
XLogP3:
1.4  

Upstream Synthesis Route

[1]JournalofOrganicChemistry,2015,vol.80,#24,p.11953-11962

[2]ChemistryLetters,2003,vol.32,#12,p.1186-1187

[3]Patent:US2004/118673,2004,A1,.Locationinpatent:Page7

[4]BioorganicChemistry,2018,vol.80,p.408-421

[5]AngewandteChemie-InternationalEdition,2014,vol.53,#30,p.7785-7788

[6]Angew.Chem.,2014,vol.53,#30,p.7919-7922,4

[7]JournaloftheAmericanChemicalSociety,1951,vol.73,p.2239

[8]ChemickeZvesti,1953,vol.7,p.457,460

[9]Chem.Abstr.,1955,p.5493

[10]ChemischeBerichte,1930,vol.63,p.3029,3043

[1]EuropeanJournalofMedicinalChemistry,2012,vol.57,p.344-361

[2]BioorganicandMedicinalChemistryLetters,2014,vol.24,#24,p.5727-5730

[3]Patent:KR101633655,2016,B1,

[4]BioorganicandMedicinalChemistry,2018,vol.26,#14,p.3925-3938

[1]Patent:CN107602462,2018,A,

[1]JournalofMedicinalChemistry,2014,vol.57,#10,p.4173-4184

[2]Patent:WO2015/167825,2015,A1,.Locationinpatent:Page/Pagecolumn102

Downstream Synthesis Route

[1]BollettinoChimicoFarmaceutico,1959,vol.98,p.646,652

[1]JournalofOrganicChemistry,2015,vol.80,p.11953-11962

[2]ChemistryLetters,2003,vol.32,p.1186-1187

[3]Patent:US2004/118673,2004,A1.Locationinpatent:Page7

[4]BioorganicChemistry,2018,vol.80,p.408-421

[5]AngewandteChemie-InternationalEdition,2014,vol.53,p.7785-7788    Angew.Chem.,2014,vol.53,p.7919-7922,4

[6]EuropeanJournalofMedicinalChemistry,2019,vol.170,p.45-54

[7]JournaloftheAmericanChemicalSociety,1951,vol.73,p.2239

[8]ChemickeZvesti,1953,vol.7,p.457,460    Chem.Abstr.,1955,p.5493

[9]ChemischeBerichte,1930,vol.63,p.3029,3043

[1]OrganicandBiomolecularChemistry,2005,vol.3,p.2150-2154

[2]Tetrahedron,2009,vol.65,p.8690-8696

[3]Molecules,2016,vol.21

[4]BioorganicandMedicinalChemistry,2017,vol.25,p.5726-5732

[5]Molecules,2020,vol.25

[6]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.5727-5730

[7]Patent:KR101633655,2016,B1.Locationinpatent:Page/Pagecolumn14

[8]Patent:CN107602462,2018,A.Locationinpatent:Paragraph0059;0060;0061;0062

[9]BollettinoChimicoFarmaceutico,1959,vol.98,p.646,652

[10]DissertationesPharmaceuticae,1958,vol.10,p.7,10    Chem.Abstr.,1958,p.20221

[11]TetrahedronLetters,1991,vol.32,p.5625-5628

[12]JournaloftheChemicalSociety.PerkintransactionsI,1994,p.461-470

[13]EuropeanJournalofMedicinalChemistry,2002,vol.37,p.961-972

[14]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.3181-3184

[15]JournaloftheAmericanChemicalSociety,2005,vol.127,p.8686-8696

[16]JournalofMedicinalChemistry,2005,vol.48,p.7426-7436

[17]Heterocycles,2006,vol.70,p.45-50

[18]TetrahedronLetters,2004,vol.45,p.3359-3362

[19]CarbohydrateResearch,2007,vol.342,p.1651-1660

[20]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.2301-2305

[21]JournalofMedicinalChemistry,2009,vol.52,p.807-817

[22]JournalofMedicinalChemistry,2010,vol.53,p.1755-1762

[23]JournalofMedicinalChemistry,2010,vol.53,p.3964-3972

[24]ChemMedChem,2010,vol.5,p.2016-2025

[25]ChemicalBiologyandDrugDesign,2013,vol.81,p.389-398

[26]Patent:US2014/24639,2014,A1.Locationinpatent:Paragraph0124

[27]EuropeanJournalofMedicinalChemistry,2014,vol.82,p.545-551

[28]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.2309-2314

[29]JournalofOrganicChemistry,2014,vol.79,p.3537-3546

[30]EuropeanJournalofMedicinalChemistry,2014,vol.87,p.398-412

[31]EuropeanJournalofMedicinalChemistry,2014,vol.87,p.461-470

[32]ChemMedChem,2014,vol.9,p.2725-2743

[33]EuropeanJournalofMedicinalChemistry,2015,vol.87,p.461-470

[34]EuropeanJournalofMedicinalChemistry,2015,vol.93,p.300-307

[35]EuropeanJournalofMedicinalChemistry,2015,vol.95,p.473-482

[36]Lettersindrugdesignanddiscovery,2015,vol.12,p.20-28

[37]EuropeanJournalofMedicinalChemistry,2015,vol.97,p.32-41

[38]EuropeanJournalofMedicinalChemistry,2015,vol.90,p.889-896

[39]JournalofMedicinalChemistry,2015,vol.58,p.5242-5255

[40]JournalofMedicinalChemistry,2015,vol.58,p.4529-4549

[41]EuropeanJournalofMedicinalChemistry,2015,vol.103,p.506-515

[42]Chemico-BiologicalInteractions,2016,vol.251,p.1-9

[43]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.2957-2964

[44]MedicinalChemistryResearch,2016,vol.25,p.1074-1086

[45]AsianJournalofChemistry,2016,vol.28,p.1895-1898

[46]Patent:US2016/168100,2016,A1.Locationinpatent:Paragraph0335

[47]Molecules,2016,vol.21

[48]MedicinalChemistryResearch,2017,vol.26,p.603-614

[49]JournaloftheBrazilianChemicalSociety,2017,vol.28,p.475-484

[50]EuropeanJournalofMedicinalChemistry,2017,vol.133,p.319-328

[51]MedChemComm,2017,vol.8,p.755-766

[52]ChemMedChem,2017,vol.12,p.1369-1379

[53]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.4506-4511

[54]Patent:CN104910174,2017,B.Locationinpatent:Paragraph0035;0036

[55]RSCAdvances,2018,vol.8,p.6231-6241

[56]BioorganicandMedicinalChemistry,2018,vol.26,p.3925-3938

[57]InternationalJournalofMolecularSciences,2018,vol.19

[58]Patent:CN108503648,2018,A.Locationinpatent:Paragraph0065;0067;0069

[59]JournalofOrganicChemistry,2018,vol.83,p.12549-12558

[60]EuropeanJournalofMedicinalChemistry,2019,vol.167,p.414-425

[61]EuropeanJournalofMedicinalChemistry,2019,vol.172,p.71-94

[62]Patent:CN109516926,2019,A.Locationinpatent:Paragraph0007;0008

[63]ChemicalCommunications,2019,vol.55,p.4407-4410

[64]JournalofMedicinalChemistry,2019,vol.62,p.4013-4031

[65]EuropeanJournalofOrganicChemistry,2019,vol.2019,p.3677-3686

[66]EuropeanJournalofOrganicChemistry,2019,vol.2019,p.4662-4674

[67]EuropeanJournalofMedicinalChemistry,2019,vol.179,p.667-679

[68]EuropeanJournalofMedicinalChemistry,2019,vol.182

[1]Molecules,2018,vol.23

[2]ChemicalBiologyandDrugDesign,2013,vol.81,p.389-398

[3]BioorganicChemistry,2019,vol.88

[4]CanadianJournalofChemistry,1970,vol.48,p.3882-3888

[5]TetrahedronLetters,2004,vol.45,p.3359-3362

[6]JournalofChemistry,2019,vol.2019

[1]JournalofOrganicChemistry,2002,vol.67,p.7861-7864

[2]Synlett,2000,p.1439-1442

[3]ChineseChemicalLetters,2017,vol.28,p.1159-1162

[4]Tetrahedron,2005,vol.61,p.4043-4052

Literature

Title: Enantioselective sequential conjugate addition-allylation reactions: a concise total synthesis of (+)-podophyllotoxin.

Journal: Organic letters 20090205

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Anti-stress effects of 3,4,5-trimethoxycinnamic acid, an active constituent of roots of Polygala tenuifolia (Onji).

Journal: Biological & pharmaceutical bulletin 20040801

Title: Biosynthesis of podophyllotoxin in Linum album cell cultures.

Journal: Planta 20021001

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 20329-98-0
1135-24-6

1135-24-6

 127427-04-7

127427-04-7

 144878-40-0

144878-40-0

 16909-11-8

16909-11-8

 17570-26-2

17570-26-2

 20329-96-8

20329-96-8
Building Blocks
More >
Tags:20329-98-0 Molecular Formula|20329-98-0 MDL|20329-98-0 SMILES|20329-98-0 3,4,5-TRIMETHOXYCINNAMIC ACID